US Stock MarketDetailed Quotes

KTRA Kintara Therapeutics

Watchlist
  • 0.1778
  • +0.0016+0.91%
Close Oct 11 16:00 ET
  • 0.1799
  • +0.0021+1.18%
Post 20:01 ET
9.90MMarket Cap-555P/E (TTM)

Kintara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-42.88%8.45M
-28.78%2.39M
-36.86%2.09M
-70.88%1.02M
-36.25%2.96M
-34.77%14.8M
-38.64%3.35M
-38.37%3.3M
-40.64%3.5M
-22.19%4.65M
Selling and administrative expenses
5.52%5.79M
79.42%2.28M
15.11%1.49M
-36.94%908K
-25.22%1.1M
-26.95%5.49M
-12.45%1.27M
-31.16%1.3M
-27.75%1.44M
-32.28%1.48M
-General and administrative expense
5.52%5.79M
79.42%2.28M
15.11%1.49M
-36.94%908K
-25.22%1.1M
-26.95%5.49M
-12.45%1.27M
-31.16%1.3M
-27.75%1.44M
-32.28%1.48M
Research and development costs
-71.40%2.66M
-95.13%101K
-70.47%592K
-94.61%111K
-41.37%1.86M
-38.63%9.31M
-48.15%2.08M
-42.29%2.01M
-47.23%2.06M
-16.40%3.17M
Operating profit
42.88%-8.45M
28.78%-2.39M
36.86%-2.09M
70.88%-1.02M
36.25%-2.96M
34.77%-14.8M
38.64%-3.35M
38.37%-3.3M
40.64%-3.5M
22.19%-4.65M
Net non-operating interest income expense
1.46%139K
335.71%61K
89.74%74K
-95.56%2K
-94.87%2K
878.57%137K
27.27%14K
3,800.00%39K
4,400.00%45K
3,800.00%39K
Total other finance cost
-1.46%-139K
-335.71%-61K
-89.74%-74K
95.56%-2K
94.87%-2K
-878.57%-137K
-27.27%-14K
-3,800.00%-39K
-4,400.00%-45K
-3,800.00%-39K
Other net income (expense)
-180.00%-8K
0
-6K
-118.18%-2K
42.86%10K
0
-200.00%-1K
175.00%11K
Gain on sale of security
-180.00%-8K
--0
----
---6K
-118.18%-2K
42.86%10K
--0
-200.00%-1K
----
175.00%11K
Income before tax
43.20%-8.32M
30.31%-2.32M
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
Income tax
Net income
43.20%-8.32M
30.31%-2.32M
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
Net income continuous Operations
43.20%-8.32M
30.31%-2.32M
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
Minority interest income
Net income attributable to the parent company
43.20%-8.32M
30.31%-2.32M
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
Preferred stock dividends
-51.08%181K
0.00%2K
0.00%2K
0.00%2K
-51.92%175K
-85.02%370K
0.00%2K
0.00%2K
0.00%2K
-85.23%364K
Other preferred stock dividends
Net income attributable to common stockholders
43.40%-8.5M
30.30%-2.33M
38.36%-2.01M
70.34%-1.03M
36.75%-3.14M
40.24%-15.02M
38.75%-3.34M
39.04%-3.27M
41.37%-3.46M
41.16%-4.96M
Basic earnings per share
96.55%-0.32
97.84%-0.0421
97.42%-0.05
88.57%-0.24
46.02%-1.83
64.07%-9.27
42.82%-1.95
64.40%-1.94
65.40%-2.1
72.88%-3.39
Diluted earnings per share
96.55%-0.32
97.84%-0.0421
97.42%-0.05
88.57%-0.24
46.02%-1.83
64.07%-9.27
42.82%-1.95
64.40%-1.94
65.40%-2.1
72.88%-3.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -42.88%8.45M-28.78%2.39M-36.86%2.09M-70.88%1.02M-36.25%2.96M-34.77%14.8M-38.64%3.35M-38.37%3.3M-40.64%3.5M-22.19%4.65M
Selling and administrative expenses 5.52%5.79M79.42%2.28M15.11%1.49M-36.94%908K-25.22%1.1M-26.95%5.49M-12.45%1.27M-31.16%1.3M-27.75%1.44M-32.28%1.48M
-General and administrative expense 5.52%5.79M79.42%2.28M15.11%1.49M-36.94%908K-25.22%1.1M-26.95%5.49M-12.45%1.27M-31.16%1.3M-27.75%1.44M-32.28%1.48M
Research and development costs -71.40%2.66M-95.13%101K-70.47%592K-94.61%111K-41.37%1.86M-38.63%9.31M-48.15%2.08M-42.29%2.01M-47.23%2.06M-16.40%3.17M
Operating profit 42.88%-8.45M28.78%-2.39M36.86%-2.09M70.88%-1.02M36.25%-2.96M34.77%-14.8M38.64%-3.35M38.37%-3.3M40.64%-3.5M22.19%-4.65M
Net non-operating interest income expense 1.46%139K335.71%61K89.74%74K-95.56%2K-94.87%2K878.57%137K27.27%14K3,800.00%39K4,400.00%45K3,800.00%39K
Total other finance cost -1.46%-139K-335.71%-61K-89.74%-74K95.56%-2K94.87%-2K-878.57%-137K-27.27%-14K-3,800.00%-39K-4,400.00%-45K-3,800.00%-39K
Other net income (expense) -180.00%-8K0-6K-118.18%-2K42.86%10K0-200.00%-1K175.00%11K
Gain on sale of security -180.00%-8K--0-------6K-118.18%-2K42.86%10K--0-200.00%-1K----175.00%11K
Income before tax 43.20%-8.32M30.31%-2.32M38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M
Income tax
Net income 43.20%-8.32M30.31%-2.32M38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M
Net income continuous Operations 43.20%-8.32M30.31%-2.32M38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M
Minority interest income
Net income attributable to the parent company 43.20%-8.32M30.31%-2.32M38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M
Preferred stock dividends -51.08%181K0.00%2K0.00%2K0.00%2K-51.92%175K-85.02%370K0.00%2K0.00%2K0.00%2K-85.23%364K
Other preferred stock dividends
Net income attributable to common stockholders 43.40%-8.5M30.30%-2.33M38.36%-2.01M70.34%-1.03M36.75%-3.14M40.24%-15.02M38.75%-3.34M39.04%-3.27M41.37%-3.46M41.16%-4.96M
Basic earnings per share 96.55%-0.3297.84%-0.042197.42%-0.0588.57%-0.2446.02%-1.8364.07%-9.2742.82%-1.9564.40%-1.9465.40%-2.172.88%-3.39
Diluted earnings per share 96.55%-0.3297.84%-0.042197.42%-0.0588.57%-0.2446.02%-1.8364.07%-9.2742.82%-1.9564.40%-1.9465.40%-2.172.88%-3.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data